Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ruggenenti

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of the American Society of Nephrology : JASN|June 11, 1999
Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpuraM Galbusera, A Benigni, S Paris, et al.
Transplantation|May 27, 1997
Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunctionF Casiraghi, P Ruggenenti, M Noris, et al.
Journal of the American Society of Nephrology : JASN|December 16, 1998
The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacinN Perico, A Remuzzi, F Sangalli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 29, 2000
ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndromeP Ruggenenti, L Mosconi, G Vendramin, et al.
Blood|August 15, 1989
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndromeP M Mannucci, R Lombardi, A Lattuada, et al.
Kidney International|January 5, 2000
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1A Perna, P Ruggenenti, A Testa, et al.
Diabetologia|July 1, 1993
Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusionS De Cosmo, K Earle, A Morocutti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1994
Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patientsP Ruggenenti, L Mosconi, L Bianchi, et al.
Journal of the American Society of Nephrology : JASN|May 8, 1999
In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in NefrologiaP Ruggenenti, A Perna, R Benini, et al.
Lancet (London, England)|January 28, 1995
alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpuraM Galbusera, P Ruggenenti, M Noris, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of the American Society of Nephrology : JASN|June 11, 1999
Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpuraM Galbusera, A Benigni, S Paris, et al.
Transplantation|May 27, 1997
Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunctionF Casiraghi, P Ruggenenti, M Noris, et al.
Journal of the American Society of Nephrology : JASN|December 16, 1998
The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacinN Perico, A Remuzzi, F Sangalli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 29, 2000
ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndromeP Ruggenenti, L Mosconi, G Vendramin, et al.
Blood|August 15, 1989
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndromeP M Mannucci, R Lombardi, A Lattuada, et al.
Kidney International|January 5, 2000
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1A Perna, P Ruggenenti, A Testa, et al.
Diabetologia|July 1, 1993
Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusionS De Cosmo, K Earle, A Morocutti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1994
Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patientsP Ruggenenti, L Mosconi, L Bianchi, et al.
Journal of the American Society of Nephrology : JASN|May 8, 1999
In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in NefrologiaP Ruggenenti, A Perna, R Benini, et al.
Lancet (London, England)|January 28, 1995
alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpuraM Galbusera, P Ruggenenti, M Noris, et al.
Pageof 10